Cytosorbents
CTSO
#9825
Rank
C$63.38 M
Marketcap
C$1.01
Share price
-1.20%
Change (1 day)
-18.93%
Change (1 year)

Cytosorbents (CTSO) - Cash on Hand

Cash on Hand as of June 2025 : C$14.1 Million

According to Cytosorbents's latest financial reports the company has C$14.1 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cytosorbents - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$4.7 M-74.89%
2023-12-31C$18.74 M-37.63%
2022-12-31C$30.04 M-54.78%
2021-12-31C$66.44 M-27.04%
2020-12-31C$91.06 M470.02%
2019-12-31C$15.97 M-47.57%
2018-12-31C$30.47 M39.92%
2017-12-31C$21.77 M208.96%
2016-12-31C$7.04 M-32.33%
2015-12-31C$10.41 M61.73%
2014-12-31C$6.44 M177.15%
2013-12-31C$2.32 M35.13%
2012-12-31C$1.71 M42.47%
2011-12-31C$1.2 M14.39%
2010-12-31C$1.05 M-37.15%
2009-12-31C$1.67 M-53.17%
2008-12-31C$3.58 M1598.43%
2007-12-31C$0.21 M-93.69%
2006-12-31C$3.34 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Meridian Bioscience
VIVO
C$0.11 B 698.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
C$2.59 B 18,315.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
C$1.76 B 12,395.10%๐Ÿ‡บ๐Ÿ‡ธ USA